Fortune Journals is an international, peer-reviewed open access publisher dedicated to the rapid dissemination of high-quality research across medicine, clinical science, life sciences, and related disciplines. We are committed to making cutting-edge scientific knowledge freely accessible to researchers, clinicians, and the global academic community — without subscription barriers.
Our growing portfolio of journals covers a broad spectrum of biomedical and life science fields, each supported by a distinguished Editorial Board of globally recognized experts who uphold rigorous scientific and ethical standards. Every article published with Fortune Journals is permanently archived and freely available under the Creative Commons Attribution License (CC BY), ensuring unrestricted use and maximum visibility for authors' work.
Our mission is to accelerate the advancement of science by providing an open, transparent, and efficient publishing platform that removes barriers to knowledge. Fortune Journals supports researchers worldwide — particularly those in developing countries and institutions with limited library resources — by ensuring that validated, peer-reviewed research is freely available to anyone, anywhere, at any time.
We believe that open access is not simply a publishing model — it is a fundamental step toward democratizing science. By making research openly accessible, we help amplify the impact of every study published with us and contribute to a faster, more connected global research community.
Articles are indexed in PubMed, PubMed Central, and other leading databases, ensuring maximum discoverability for your research worldwide.
All submissions undergo a thorough, double-blind peer review process conducted by independent experts to ensure scientific integrity and quality.
We are committed to timely editorial decisions and fast publication turnaround so your research reaches the community without unnecessary delay.
All published articles are permanently and freely accessible online under the Creative Commons CC BY license — no paywalls, ever.
Authors retain full copyright of their work. The CC BY license allows anyone to share and build upon the research with appropriate attribution.
Our Editorial and Review Boards comprise leading scientists and clinicians committed to maintaining the highest levels of scientific rigor.
Fortune Journals operates a rigorous, multi-stage editorial process designed to uphold the highest standards of scientific quality, transparency, and integrity.
Fortune Journals is committed to the highest standards of publication ethics. We follow the guidelines established by the Committee on Publication Ethics (COPE) and expect all authors, reviewers, and editors to adhere to these principles. Plagiarism, data fabrication, duplicate submission, and inappropriate authorship are taken with zero tolerance.
Submitted manuscripts may be screened for originality using plagiarism detection tools. Any confirmed misconduct will result in rejection of the manuscript or retraction of a published article, with notification to the authors' institutions where appropriate.
All articles published in Fortune Journals are made immediately and permanently available online free of charge. There are no subscription fees, access barriers, or embargo periods. Content is distributed under the Creative Commons Attribution License (CC BY), which allows others to freely share, adapt, and build upon published work provided the original source is properly cited.
Publication costs are covered through Article Processing Charges (APCs), enabling the long-term sustainability of our open access model while keeping research freely accessible to all readers globally.
Join thousands of researchers who have shared their findings with the global scientific community through Fortune Journals.
Submit Your Manuscript© 2016-2026, Copyrights Fortune Journals. All Rights Reserved!